Good Peptide powder peptides Peptide Research Peptide peptide Chemical Factory peptides peptides peptides peptide ghk-cu reta
TDS 7526 Inquiries
2381089-83-2
Pharmaceutical Grade
99.8%
tianjin
aobosi
5mg 10mg 15mg 20mg 30mg 50/60mg per vial; 10vials/box
Yes
2026-05-24
peptide
-
Product Details
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceRetatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide inhibits human GCGR, GIPR and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively and mouse GCGR, GIPR, and GLP-1R with EC50 values of 2.32, 0.191 and 0.794 nM, respectively. It is an important tool for obesity research.Retatrutide potently activates the GLP-1R signaling pathway to stimulate glucose-dependent insulin secretion through activity at the GIP receptor (GIPR) or the GLP-1R.Retatrutide is a synthetic peptide with glucose-lowering effects. It is an antidiabetic agent against type 2 diabetes (T2D), stimulating insulin and suppressing glucagon secretion in a glucose-dependent manner.Retatrutide was also shown to delay gastric emptying, lower fasting and postprandial glucose concentration, decrease food intake and reduce body weight in patients with type 2 diabetes.
Retatrutide (LY-3437943) was discovered by the American pharmaceutical company Eli Lilly and Company. It is a triple glucagon hormone receptor agonist (GLP-1, GIP, and GCGR receptors) for obesity. The 2024 Lasker~DeBakey Clinical Medical Research Award has been given to Joel Habener and Svetlana Mojsov for their discovery of a new hormone GLP-1(7-37) and to Lotte Knudsen for her role in developing sustained acting versions of this hormone as a treatment for obesity.Certificates-
TDS
Basic Info-
Product Name:
Retatrutide
Other Name:Retatrutide;GIPR/GLP-1R;LY3437943Retatrutide;Retalutide;Retatrutide (sodium salt);Retatrutide RT5;retatrutide 5mg;Retatratide
CAS No.:2381089-83-2
InChIKeys:MLOLQJNKXBNWFW-SAGGEDDASA-N
Molecular Weight:0
EC Number:200-001-8
Color/Form:White lyophilized
Categories:
Characteristics-
Water Solubility:
Soluble in water (5mg/ml).
Storage Conditions:-20°C
Critical Temperature & Pressure:-20°C
Research-
Class:
Triple agonist — GCGR, GIPR, GLP-1R
Status:Investigational (Phase 3)
Mechanism:Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.
EC50 (Human GCGR):5.79 nM
EC50 (Mouse GIPR):0.191 nM
EC50 (Mouse GLP1R):0.794 nM
EC50 (Mouse GCGR):2.32 nM
EC50 (Human GLP1R):0.775 nM
EC50 (Human GIPR):0.0643 nM
Source:Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI
Clinical Development:
References-
ChEMBL:DrugBank:KEGG DRUG:PubChem:Literature:
NEJM: Jastreboff et al. (2023) — Phase 2 Trial ; FDA Drugs@FDA
Disclaimer:Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
peptide
-
Location:
Room 1601-1, Building 1, Yuanlun Mansion, No. 350 Qifei Road, Changhe Street, Binjiang District, Hangzhou City, Zhejiang Province, China
-
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
7 days
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
11-50
-
Year of Establishment:
2026
-
-
Inquiry History7526 Inquiries
Country Product Purchase Quantity Date Posted
Colombia
Retatrutide
10 MG Nov 3, 2026
Czech
Retatrutide
1 G Nov 3, 2026
Slovakia
Retatrutide
30 MG Nov 2, 2026
France
Retatrutide
5 MG Nov 2, 2026
United States
Retatrutide
10 MG Nov 2, 2026
South Africa
Retatrutide
32 MG Nov 2, 2026
United States
Retatrutide
2 MT Nov 2, 2026
United States
Retatrutide
1 KG Nov 2, 2026
United States
Retatrutide
10 MT Nov 2, 2026
United States
Retatrutide
4 MT Nov 2, 2026
United Kingdom
Retatrutide
1 KG Nov 1, 2026
Poland
Retatrutide
3 G Nov 1, 2026
United Kingdom
Retatrutide
10 MT Nov 1, 2026
United Kingdom
Retatrutide
300 MG Oct 31, 2026
Canada
Retatrutide
20 MG Oct 31, 2026
South Korea
Retatrutide
1 G Oct 31, 2026
South Africa
Retatrutide
5 MT Oct 31, 2026
United States
Retatrutide
100 MT Oct 31, 2026
Poland
Retatrutide
1 BOU Oct 30, 2026
United States
Retatrutide
10 PCS Oct 30, 2026 Post an enquiry for this product
More from this Seller
-
-
-
Hot Sale 99.5% High Purity Mazdutide Peptides Vials US Warehouse Wholesale Fast Safe Global Logistics
Biochemical Grade / 99%
$30-35/MT FOB
-
-
-
-
Snap-8 |99% High Purity Peptide Factory supply CAS 868844-74-0 Snap-8 10mg
Pharmaceutical Grade / 99%
$30-37/BOU FOB
-
-
-
-
Vilon VI20 L-Lysyl-L-Glutamic Acid (Lys-Glu) peptide
Pharmaceutical Grade / 99.9%
-
-
-
-
Premium High Quality Vilon Dipeptide Factory Direct Fast Safe Global Bulk Lab Raw Material Dispatch
Pharmaceutical Grade / 99%
$15-18/MT FOB
-
-
-
-
99.5% High Quality Freeze-dried Pinealon Raw Material Fast Factory Worldwide Bulk Dispatch
Pharmaceutical Grade / 99%
-
